Published in Medical Letter on the CDC and FDA, August 30th, 2009
"Our objective was to determine whether methylene blue, already US Food and Drug Administration approved for other indications, has useful near-infrared fluorescence properties for image-guided cardiac surgery. The optical properties of methylene blue were measured after dissolution in 100% serum. Biodistribution and clearance were quantified in organs and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA